14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.75 $7.35 Wednesday, 1st May 2024 FATE stock ended at $4.09. This is 3.54% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 11.47% from a day low at $3.88 to a day high of $4.33.
90 days $3.75 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Jun 16, 2020 $32.50 $32.76 $30.74 $31.58 879 315
Jun 15, 2020 $30.14 $31.93 $29.94 $31.91 993 668
Jun 12, 2020 $30.94 $31.36 $29.30 $30.75 1 179 633
Jun 11, 2020 $31.65 $32.37 $29.61 $29.85 1 206 297
Jun 10, 2020 $33.54 $34.18 $32.41 $32.99 1 236 932
Jun 09, 2020 $29.70 $35.77 $29.70 $32.72 8 382 756
Jun 08, 2020 $28.66 $29.00 $27.64 $28.31 722 250
Jun 05, 2020 $30.59 $30.95 $28.08 $28.21 1 103 970
Jun 04, 2020 $30.88 $31.78 $29.40 $30.04 908 231
Jun 03, 2020 $32.16 $32.49 $30.86 $30.88 582 496
Jun 02, 2020 $31.65 $32.04 $30.41 $31.97 624 028
Jun 01, 2020 $32.22 $32.43 $31.26 $31.68 720 852
May 29, 2020 $32.40 $33.14 $31.30 $32.43 844 907
May 28, 2020 $33.61 $34.31 $32.09 $32.22 587 862
May 27, 2020 $34.03 $34.13 $31.55 $33.09 1 021 388
May 26, 2020 $35.65 $37.24 $33.70 $33.79 1 217 270
May 22, 2020 $33.72 $35.25 $32.12 $35.23 1 360 837
May 21, 2020 $31.15 $33.81 $30.34 $33.54 1 130 763
May 20, 2020 $29.30 $31.10 $29.10 $30.99 1 290 060
May 19, 2020 $29.42 $30.00 $28.81 $28.86 701 016
May 18, 2020 $30.07 $30.40 $28.88 $29.60 1 071 726
May 15, 2020 $26.69 $29.10 $26.23 $28.45 1 177 772
May 14, 2020 $26.90 $27.44 $26.15 $26.62 1 066 792
May 13, 2020 $29.56 $29.72 $25.60 $27.44 1 340 566
May 12, 2020 $29.15 $32.05 $28.50 $28.75 1 791 134
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT